Volume 88, Issue 4, Pages (October 2015)

Slides:



Advertisements
Similar presentations
Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup
Advertisements

Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto 
Melamine toxicity: one more culprit in calcium kidney lithiasis
Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward  Adeera Levin, Paul E. Stevens  Kidney International 
Propofol-related green urine
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Volume 83, Issue 3, Pages (March 2013)
ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target  Szu-Chun Hung, Der-Cherng Tarng  Kidney International 
Prehypertension and chronic kidney disease: the ox or the plow?
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Reassessment of the care of the patient with chronic kidney disease
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 77, Issue 1, Pages 6-8 (January 2010)
Peter A. McCullough, MD, MPH  Advances in Chronic Kidney Disease 
Audit-based education: a potentially effective program for improving guideline achievement in CKD patients  Moniek C.M. de Goeij, Joris I. Rotmans  Kidney.
Volume 85, Issue 3, Pages (March 2014)
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Volume 72, Issue 6, Pages (September 2007)
Comorbidity and confounding in end-stage renal disease
Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing?  Gautam R. Shroff, Charles A. Herzog 
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
Gary C.W. Chan, Sydney C.W. Tang  Kidney International 
Use of vitamin D in chronic kidney disease patients
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Bisphosphonate safety and efficacy in chronic kidney disease
Volume 80, Issue 8, Pages (October 2011)
The calcium–phosphorus in guidelines for CKD-MBD
Melamine toxicity: one more culprit in calcium kidney lithiasis
Volume 70, Issue 7, Pages (October 2006)
Volume 73, Issue 12, Pages (June 2008)
Volume 84, Issue 4, Pages (October 2013)
Volume 76, Issue 6, Pages (September 2009)
A physician's perseverance uncovers problems in a key nephrology study
Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto 
Can we prevent donor-specific antibodies from developing after ABO-incompatible kidney transplantation?  Lionel Rostaing, Nassim Kamar  Kidney International 
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Volume 74, Issue 8, Pages (October 2008)
Methods for guideline development
Volume 93, Issue 1, Pages (January 2018)
Volume 87, Issue 1, Pages (January 2015)
Volume 56, Issue 4, Pages (October 1999)
The global challenge of chronic kidney disease
Nephrology Crossword: Glomerulonephritis
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease  S. Susan Hedayati, Venkata Yalamanchili,
Cardiovascular calcification in patients with chronic renal failure: Are we on target with this risk factor?  Peter A. Mccullough, Sandeep Soman  Kidney.
Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell  Kara K. Wools-Kaloustian, Samir K. Gupta  Kidney.
Vitamin D in chronic kidney disease: is the jury in?
Volume 82, Issue 9, Pages (November 2012)
Volume 69, Issue 11, Pages (June 2006)
Cardio-Kidney-Damage: a unifying concept
Nanocrystals seed calcification in more ways than one
The vascular secret of Klotho
Volume 72, Issue 2, Pages (July 2007)
Pablo A. Ureña Torres, Marc De Broe  Kidney International 
Volume 80, Issue 10, Pages (November 2011)
The hypothesis that abnormal BH4 metabolism impairs kidney function
Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller 
Volume 75, Issue 7, Pages (April 2009)
Volume 76, Issue 1, Pages (July 2009)
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
Cell biological and physicochemical aspects of arterial calcification
Volume 74, Issue 10, Pages (November 2008)
Sugar-sweetened beverages and chronic disease
Dhanya Mohan, Mohammed Railey
Presentation transcript:

Volume 88, Issue 4, Pages 660-662 (October 2015) Klotho upregulation by rapamycin protects against vascular disease in CKD  Takayuki Hamano  Kidney International  Volume 88, Issue 4, Pages 660-662 (October 2015) DOI: 10.1038/ki.2015.223 Copyright © 2015 International Society of Nephrology Terms and Conditions

Figure 1 The effect of mTOR inhibition on two types of vasculopathy often seen in patients with chronic kidney disease. mTOR inhibitors, such as rapamycin and everolimus, stabilize atherosclerotic plaque and/or regress atherosclerosis by inhibiting VSMC proliferation, promoting protective autophagy, and attenuating nuclear factor-κB (NF-κB) activation. The protective effect of mTOR inhibitors on medial calcification was also reported. The main mechanisms include the upregulation of Klotho. Kidney International 2015 88, 660-662DOI: (10.1038/ki.2015.223) Copyright © 2015 International Society of Nephrology Terms and Conditions